Real-life efficacy of generic sofosbuvir/ledipasvir for treatment of Iranian patients with chronic hepatitis C: A cohort study

BACKGROUND: Treatment of hepatitis C virus (HCV) infection with recently introduced direct-acting antiviral agents (DAA) is effective and safe, however there is little known regarding safety and efficacy of generic DAAs in the real-life clinical setting. This study aimed to evaluate the efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharafi, Heidar, Alavian, Seyed Hoda, Behnava, Bita, Saeid Rezaee-Zavareh, Mohammad, Nikbin, Mehri, Alavian, Seyed Moayed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Babol University of Medical Sciences 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992720/
https://www.ncbi.nlm.nih.gov/pubmed/32042385
http://dx.doi.org/10.22088/cjim.11.1.41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992720/
https://www.ncbi.nlm.nih.gov/pubmed/32042385
http://dx.doi.org/10.22088/cjim.11.1.41

Ejemplares similares